ABT

ABBOTT LABORATORIES

Healthcare | Mega Cap

$1.16

EPS Forecast

$11,021

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$1.16

Revenue Forecast:

$11,021

EPS Surprise Forecast:

$0.017

Revenue Surprise Forecast:

-$13

Post-release price volatility - Medium

Post-release Overnight Move:

±4.4%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

70%

Probability of beating revenue consensus:

48%

Probability of beating both EPS & revs consensus:

40%

Probability of missing both EPS & revs consensus:

22%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.53

Earnings volatility

EPS standard deviation:

$0.10

Revenue standard deviation:

$202

As % of share price:

0.09% LOW

As % of market cap:

0.11% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$1.32

Revenue 95th %ile:

$11,366

EPS 75th %ile:

$1.20

Revenue 75th %ile:

$11,120

EPS 25th %ile:

$1.14

Revenue 25th %ile:

$10,938

EPS 5th %ile:

$1.08

Revenue 5th %ile:

$10,752

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

46% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

39% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$2

Bid-ask per Share:

$0.025